methylprednisolone tablets, USP Dosepak, 4 mg
Recalled by Greenstone Llc
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Greenstone Llc has recalled methylprednisolone tablets, USP Dosepak, 4 mg, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on February 4, 2026 and was initiated on January 15, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers methylprednisolone tablets, USP Dosepak, 4 mg, with approximately 3456 cartons affected. The company behind the recall is Greenstone Llc, based in Peapack, NJ. The FDA describes the product as: “methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2”
Why was methylprednisolone tablets, USP Dosepak, 4 mg recalled?
According to the FDA, the stated reason for the recall is: “Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.”
What should you do?
If you think you may have bought methylprednisolone tablets, USP Dosepak, 4 mg, compare it against the product description and identifying codes (Lot # LG7675, Exp. Date Nov 2026) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Greenstone Llc or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- February 4, 2026
- Recall started
- January 15, 2026
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was methylprednisolone tablets, USP Dosepak, 4 mg recalled?+
According to the FDA: Labeling: Not Elsewhere Classified.
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have methylprednisolone tablets, USP Dosepak, 4 mg?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0299-2026. Information last synced from the FDA on July 6, 2026.